Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:AXON News 5 November 2025 - 28 January 2026

AppLovin stock price rises in midday trade as Needham turns bullish on Axon e-commerce push

AppLovin stock price rises in midday trade as Needham turns bullish on Axon e-commerce push

AppLovin shares rose 1.2% to $550.25 midday Wednesday after Needham upgraded the stock to “buy” and set a $700 target, citing gains in e-commerce ad revenue and new retail clients. Investors await the company’s Feb. 11 earnings report for more detail on Axon’s performance and advertiser growth. The SEC continues to investigate AppLovin’s data practices.
28 January 2026
···
AppLovin stock rises after Feb. 11 earnings date set as Axon checks drive focus

AppLovin stock rises after Feb. 11 earnings date set as Axon checks drive focus

AppLovin shares rose about 2.5% to $632.92 in after-hours trading Wednesday after the company announced it will report fourth-quarter and full-year 2025 results on Feb. 11, following the U.S. market close. The stock traded between $611 and $643 during the session. CEO Adam Foroughi and CFO Matthew Stumpf will host a results webinar at 5 p.m. ET that day.
8 January 2026
···
Axon Enterprise (AXON) Stock: Latest News, Analyst Forecasts, and Key Catalysts as of December 20, 2025

Axon Enterprise (AXON) Stock: Latest News, Analyst Forecasts, and Key Catalysts as of December 20, 2025

December 20, 2025 — Axon Enterprise, Inc. (NASDAQ: AXON) is ending the week back in the spotlight after a cluster of developments that matter to stock-watchers: a major capital-structure move involving its 0.50% convertible notes, fresh municipal contract headlines tied to AI-assisted policing and drones, and a notable analyst price-target cut that still kept a bullish rating in place. IE COMMUNITY NEWS+4Securities and Exchange Commission+4QuoteMedia+4 Because today is a Saturday and U.S. markets are closed, the most recent widely reported price action is from Friday, Dec. 19. AXON last traded around $594.20, up roughly 5.4% in the latest session, after
20 December 2025
·
Axon Enterprise (AXON) Stock Forecast: Tariff Hit, AI Ambitions and Wall Street’s 40% Upside View – December 11, 2025

Axon Enterprise (AXON) Stock Forecast: Tariff Hit, AI Ambitions and Wall Street’s 40% Upside View – December 11, 2025

Axon Enterprise, Inc. (NASDAQ: AXON) has had a volatile 2025. After surging to an all‑time high near $886 in August, the public‑safety technology leader now trades around $568 per share, after a 3.98% gain on December 10.MarketBeat+1 That leaves the stock roughly 35–40% below its 52‑week high, even as the underlying business continues to grow revenue above 30% year over year.StockAnalysis+1 The sharp reset followed Axon’s Q3 2025 earnings, where the company beat on revenue but missed profit expectations as U.S. tariffs squeezed margins. Shares fell about 18–20% in the two sessions after the release.Reuters+1 Yet Wall Street still sees
11 December 2025
·
Axon Stock (AXON) Today: Price, Forecasts and AI Policing Risks – December 7, 2025

Axon Stock (AXON) Today: Price, Forecasts and AI Policing Risks – December 7, 2025

Axon Enterprise (NASDAQ: AXON) has become one of the market’s most hotly debated growth stocks. After a spectacular multi‑year run, the maker of TASER devices, body cameras and public‑safety software has been hit by a sharp sell‑off in late 2025, just as it doubles down on artificial intelligence and emergency‑communications acquisitions. As of the latest trade on December 6, 2025, Axon stock changes hands at about $551 per share, giving the company a market capitalization of roughly $43 billion. Stock Titan The shares now sit around 38% below their 52‑week high of $885.92, set in early August, and are down
7 December 2025
··
Axon Enterprise (AXON) Stock Plunges on Earnings Miss – What’s Next for the Taser Maker?

Axon Enterprise (AXON) Stock Plunges on Earnings Miss – What’s Next for the Taser Maker?

Stock Price and Recent Performance (as of Nov 5, 2025) Axon’s stock has experienced whiplash in early November. After closing at $706.13 on Nov 4stockanalysis.com, shares tumbled to around $563 in pre-market trading the next daystockanalysis.com. This ~20% drop followed the company’s Q3 earnings announcement, where profits disappointed Wall Street. In fact, Axon’s stock had already been sliding for several days heading into the report – falling four days in a row from about $732 at the end of October to $706 on Nov 4stockinvest.us. To put the pullback in perspective, Axon’s year-to-date gains were nearly 19% before the earnings
5 November 2025
···

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
New York, Feb 7, 2026, 11:36 EST — Market closed. Home Depot (HD.N) shares rose about 0.7% on Friday to close at $385.15, after trading between $379.10 and $386.37. (Yahoo Finance) The next move may not come from Home Depot itself. A delayed U.S. jobs report is due on Wednesday and the Consumer Price Index (CPI), a key inflation gauge, follows on Friday, after a brief government shutdown pushed both releases back, a Reuters Week Ahead column said. (Reuters) That matters for housing-linked names because interest-rate bets can shift quickly when hiring or inflation surprises. Federal Reserve Vice Chair Philip
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop